138 related articles for article (PubMed ID: 23098696)
21. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
[TBL] [Abstract][Full Text] [Related]
22. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
Rabkin JG; Wagner GJ; Rabkin R
Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
[TBL] [Abstract][Full Text] [Related]
23. Individual psychotherapies for depressed HIV-positive patients.
Markowitz JC; Klerman GL; Clougherty KF; Spielman LA; Jacobsberg LB; Fishman B; Frances AJ; Kocsis JH; Perry SW
Am J Psychiatry; 1995 Oct; 152(10):1504-9. PubMed ID: 7573591
[TBL] [Abstract][Full Text] [Related]
24. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
25. The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus.
Birk TJ; McGrady A; MacArthur RD; Khuder S
J Altern Complement Med; 2000 Oct; 6(5):405-14. PubMed ID: 11059502
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
27. Anthroposophic therapy for chronic depression: a four-year prospective cohort study.
Hamre HJ; Witt CM; Glockmann A; Ziegler R; Willich SN; Kiene H
BMC Psychiatry; 2006 Dec; 6():57. PubMed ID: 17173663
[TBL] [Abstract][Full Text] [Related]
28. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care.
Mynors-Wallis LM; Gath DH; Day A; Baker F
BMJ; 2000 Jan; 320(7226):26-30. PubMed ID: 10617523
[TBL] [Abstract][Full Text] [Related]
29. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
[TBL] [Abstract][Full Text] [Related]
30. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial.
Bergh S; Selbæk G; Engedal K
BMJ; 2012 Mar; 344():e1566. PubMed ID: 22408266
[TBL] [Abstract][Full Text] [Related]
31. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
[TBL] [Abstract][Full Text] [Related]
32. Living well with stroke: design and methods for a randomized controlled trial of a psychosocial behavioral intervention for poststroke depression.
Mitchell PH; Teri L; Veith R; Buzaitis A; Tirschwell D; Becker K; Fruin M; Kohen R; Cain KC
J Stroke Cerebrovasc Dis; 2008; 17(3):109-15. PubMed ID: 18436150
[TBL] [Abstract][Full Text] [Related]
33. Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial.
Watanabe N; Horikoshi M; Yamada M; Shimodera S; Akechi T; Miki K; Inagaki M; Yonemoto N; Imai H; Tajika A; Ogawa Y; Takeshima N; Hayasaka Y; Furukawa TA;
Trials; 2015 Jul; 16():293. PubMed ID: 26149441
[TBL] [Abstract][Full Text] [Related]
34. Reductions in HIV risk behaviors among depressed drug injectors.
Stein MD; Anderson BJ; Solomon DA; Herman DS; Ramsey SE; Brown RA; Miller IW
Am J Drug Alcohol Abuse; 2005; 31(3):417-32. PubMed ID: 16161727
[TBL] [Abstract][Full Text] [Related]
35. A novel clinical-trial design for the study of massage therapy.
Patterson M; Maurer S; Adler SR; Avins AL
Complement Ther Med; 2008 Jun; 16(3):169-76. PubMed ID: 18534330
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
37. Massage therapy for the treatment of depression: a systematic review.
Coelho HF; Boddy K; Ernst E
Int J Clin Pract; 2008 Feb; 62(2):325-33. PubMed ID: 18081800
[TBL] [Abstract][Full Text] [Related]
38. Acute Swedish Massage Monotherapy Successfully Remediates Symptoms of Generalized Anxiety Disorder: A Proof-of-Concept, Randomized Controlled Study.
Rapaport MH; Schettler P; Larson ER; Edwards SA; Dunlop BW; Rakofsky JJ; Kinkead B
J Clin Psychiatry; 2016 Jul; 77(7):e883-91. PubMed ID: 27464321
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
Furey ML; Drevets WC
Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
[TBL] [Abstract][Full Text] [Related]
40. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial.
Simon GE; Ludman EJ; Tutty S; Operskalski B; Von Korff M
JAMA; 2004 Aug; 292(8):935-42. PubMed ID: 15328325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
